XML 85 R21.htm IDEA: XBRL DOCUMENT v3.3.0.814
Earnings per Share
9 Months Ended
Sep. 30, 2015
Earnings Per Share [Abstract]  
Earnings per Share
Earnings per Share
The Company has unvested shares of restricted stock and restricted stock units outstanding that are considered participating securities and, therefore, computes basic and diluted earnings per share under the two-class method. Basic earnings per share for the periods are based upon the weighted average number of shares of common stock outstanding during the periods. Diluted earnings per share include the effect of certain stock options.
 
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
 
2015
 
2014
 
2015
 
2014
Net income attributable to
   Westlake Chemical Corporation
 
$
183,604

 
$
167,757

 
$
535,041

 
$
495,232

Less:
 
 
 
 
 
 
 
 
Net income attributable to participating securities
 
(195
)
 
(353
)
 
(653
)
 
(1,099
)
Net income attributable to common shareholders
 
$
183,409

 
$
167,404

 
$
534,388

 
$
494,133


The following table reconciles the denominator for the basic and diluted earnings per share computations shown in the consolidated statements of operations:
 
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
 
2015
 
2014
 
2015
 
2014
Weighted average common shares—basic
 
131,664,296

 
133,299,458

 
132,301,814

 
133,199,304

Plus incremental shares from:
 
 
 
 
 
 
 
 
Assumed exercise of options
 
456,939

 
546,601

 
484,720

 
543,841

Weighted average common shares—diluted
 
132,121,235

 
133,846,059

 
132,786,534

 
133,743,145

 
 
 
 
 
 
 
 
 
Earnings per common share attributable to
   Westlake Chemical Corporation:
 
 
 
 
 
 
 
 
Basic
 
$
1.39

 
$
1.26

 
$
4.04

 
$
3.71

Diluted
 
$
1.39

 
$
1.25

 
$
4.02

 
$
3.69


Excluded from the computation of diluted earnings per share are options to purchase 315,285 and 295,825 shares of common stock for the three and nine months ended September 30, 2015, respectively. These options were outstanding during the periods reported but were excluded because the effect of including them would have been antidilutive. There were no options excluded from the computation of diluted earnings per share for the three and nine months ended September 30, 2014.